ABOUT ADVANCE

The goal of the ADVANCE project is to help health professionals, regulatory agencies, public health institutions, vaccine manufacturers and the general public make more informed decisions on benefits and risks of marketed vaccines.

News

14/02/2019

REGISTRATION OPEN: From ADVANCE To VAC4EU conference

EU Ecosystem For Monitoring Of Post-Licensure Vaccine Benefit And Risk: From... READ MORE

07/02/2019

The knowledge discovery cube framework: a reference framework for collaborative, information-driven pharmacovigilance

PhD Defence Dimitra Pappa The knowledge discovery cube framework: a reference... READ MORE

30/01/2019

ADVANCE at Global Vaccine Data Network

The Project Coordinator of ADVANCE Prof Miriam Sturkenboom will present the... READ MORE

ADVANCE TOOLBOX

ADVANCE consortium has developed the ADVANCE Toolbox which can be used by the scientific community to streamline the monitoring of the health benefits and risks of vaccines in the post licensure phase. It comprises different online open source applications that allow to transform outcome definitions into diagnosis codes, to analyse and select vaccine codes in a given vaccine coding system, assess potential impact of possible disease- and exposure misclassification, derive prevalence estimates and validity indices and visualise near real-time monitoring of the post-marketing benefits and risks of vaccines. Moreover, researchers can use ADVANCE web catalogue to conduct an assessment of the ability of databases to contribute to future vaccine benefit-risk studies.

Links